A human embryonic stem cell: scientific research has been making rapid progress but investment has been hard to attract

Britain’s international status as a location for stem cell science received a big boost on Thursday when Pfizer, the world’s largest drug company, announced plans to spend up to $60m (£41m) on a research centre in Cambridge.